X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA FRESENIUS KABI ONCO. ELDER PHARMA/
FRESENIUS KABI ONCO.
 
P/E (TTM) x -0.2 22.1 - View Chart
P/BV x 0.1 3.1 3.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
FRESENIUS KABI ONCO.
Mar-13
ELDER PHARMA/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs380176 215.9%   
Low Rs18879 239.5%   
Sales per share (Unadj.) Rs491.237.7 1,303.4%  
Earnings per share (Unadj.) Rs-3.25.1 -62.5%  
Cash flow per share (Unadj.) Rs14.46.7 214.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.542.5 885.0%  
Shares outstanding (eoy) m20.54158.23 13.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.63.4 17.1%   
Avg P/E ratio x-89.325.0 -357.3%  
P/CF ratio (eoy) x19.718.9 104.1%  
Price / Book Value ratio x0.83.0 25.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83320,135 29.0%   
No. of employees `000NA1.2 0.0%   
Total wages/salary Rs m2,179703 309.9%   
Avg. sales/employee Rs ThNM5,176.2-  
Avg. wages/employee Rs ThNM610.4-  
Avg. net profit/employee Rs ThNM699.6-  
INCOME DATA
Net Sales Rs m10,0895,963 169.2%  
Other income Rs m25718 1,425.6%   
Total revenues Rs m10,3465,981 173.0%   
Gross profit Rs m-7921,430 -55.4%  
Depreciation Rs m361258 140.1%   
Interest Rs m2,756-26 -10,601.2%   
Profit before tax Rs m-3,6531,216 -300.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,713-68 -5,451.8%   
Tax Rs m125342 36.6%   
Profit after tax Rs m-65806 -8.1%  
Gross profit margin %-7.824.0 -32.7%  
Effective tax rate %-3.428.1 -12.2%   
Net profit margin %-0.613.5 -4.8%  
BALANCE SHEET DATA
Current assets Rs m9,2405,102 181.1%   
Current liabilities Rs m9,9982,385 419.1%   
Net working cap to sales %-7.545.6 -16.5%  
Current ratio x0.92.1 43.2%  
Inventory Days Days46150 30.9%  
Debtors Days Days60113 52.9%  
Net fixed assets Rs m10,1245,148 196.6%   
Share capital Rs m206158 130.0%   
"Free" reserves Rs m5,5826,556 85.2%   
Net worth Rs m7,7346,732 114.9%   
Long term debt Rs m4,889952 513.4%   
Total assets Rs m22,88210,388 220.3%  
Interest coverage x-0.3-45.8 0.7%   
Debt to equity ratio x0.60.1 446.9%  
Sales to assets ratio x0.40.6 76.8%   
Return on assets %11.87.5 156.6%  
Return on equity %-0.812.0 -7.1%  
Return on capital %22.314.6 152.8%  
Exports to sales %3.074.5 4.1%   
Imports to sales %0.424.8 1.7%   
Exports (fob) Rs m3074,441 6.9%   
Imports (cif) Rs m431,477 2.9%   
Fx inflow Rs m3075,298 5.8%   
Fx outflow Rs m1251,772 7.1%   
Net fx Rs m1813,525 5.1%   
CASH FLOW
From Operations Rs m11,7541,274 922.5%  
From Investments Rs m-561-1,204 46.5%  
From Financial Activity Rs m-6,762-196 3,448.1%  
Net Cashflow Rs m4,432-126 -3,508.9%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 7.5 0.3 2,500.0%  
FIIs % 16.8 9.6 175.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 9.1 396.7%  
Shareholders   16,479 42,599 38.7%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DR. DATSONS LABS  DISHMAN PHARMA  FULFORD INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Strong; Consumer Durables Stocks Drag(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are trading above the dotted line. Except stocks in the consumer durables sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS